Intravitreal Fluocinolone Acetonide Implant (ILUVIEN?) for the Treatment of Retinal Conditions. A Review of Clinical Studies

被引：7
|
作者：
Mushtaq, Yusuf [1 ,2 ]
Mushtaq, Maryam M. [3 ]
Gatzioufas, Zisis [4 ,5 ]
Ripa, Matteo [6 ]
Motta, Lorenzo [7 ,9 ]
Panos, Georgios D. [1 ,2 ,8 ]
机构：
[1] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Dept Ophthalmol, Nottingham, England
[2] Univ Nottingham, Sch Med, Nottingham, England
[3] Luton & Dunstable Univ Hosp NHS Trust, Dept Acute Med, Luton, England
[4] Basel Univ Hosp, Dept Ophthalmol, Basel, Switzerland
[5] Univ Basel, Sch Med, Basel, Switzerland
[6] Fdn Policlin Univ A Gemelli IRCCS, Ophthalmol Unit, Rome, Italy
[7] East Kent Hosp Univ NHS Fdn Trust, William Harvey Hosp, Dept Ophthalmol, Canterbury, Kent, England
[8] Queens Med Ctr, Dept Ophthalmol, Derby Rd, Nottingham NG7 2UH, England
[9] William Harvey Hosp, Dept Ophthalmol, Kennington Rd, Ashford TN24 0LZ, Kent, England
来源：
DRUG DESIGN DEVELOPMENT AND THERAPY | 2023年 / 17卷
关键词：
Iluvien; steroid implant; diabetic macular oedema; intravitreal implant; posterior uveitis; retinal vein occlusion; DIABETIC MACULAR EDEMA; LONG-TERM-BENEFIT; SUSTAINED-DELIVERY; NONINFECTIOUS INTERMEDIATE; AVAILABLE THERAPIES; VITREOUS INSERTS; EFFICACY; SAFETY; INJECTION; EYES;
D O I：
10.2147/DDDT.S403259
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Fluocinolone acetonide (FAc) intravitreal implant (Iluvien (R)) is a corticosteroid implant indicated for the treatment of diabetic macular oedema (DMO) in patients who have previously received conventional treatment without good response, non- infectious posterior uveitis, and as an off-label treatment of the macular oedema secondary to retinal vein occlusion. FAc is a non -biodegradable 0.19 mg intravitreal implant which is designed to release FAc over 3 years at a rate of approximately 0.2 mcg per day. The aim of this review is to describe the special pharmacological properties of Iluvien and display the outcomes of the most important clinical trials and real-world studies regarding its efficacy and safety for the management of the above retinal disorders.
引用
收藏
页码：961 / 975
页数：15
相关论文
共 50 条
  • [41] Hypotony Maculopathy Associated With Extruded Fluocinolone Acetonide Intravitreal Implant
    Soifer, Matias
    Leite, Ryan
    Kodati, Shilpa
    JAMA OPHTHALMOLOGY, 2023, 141 (08)
  • [42] Determining the relative cost effectiveness of the fluocinolone acetonide intravitreal implant
    Dixon, Simon
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 : 1 - 2
  • [43] Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 μg intravitreal implant for diabetic macular edema
    Currie, Craig J.
    Holden, Sarah E.
    Owens, David R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 : 33 - 43
  • [44] Efficacy of the Fluocinolone Acetonide (Yutiq) Intravitreal Implant as Monotherapy for Uveitis
    Mahmud, Hamidah
    Ahmad, Tessnim R.
    Gonzales, John A.
    Stewart, Jay M.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (08) : 1603 - 1607
  • [45] RETINAL THICKNESS RESULTS PRIOR AND FOLLOWING TREATMENT WITH 0.19 MG FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR DIABETIC MACULAR EDEMA
    Carneiro, Angela M.
    Meireles, Angelina
    Sousa, Joao
    Teixeira, Carla
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [46] Three-year outcome of fluocinolone acetonide intravitreal implant (ILUVIEN) in the treatment of chronic diabetic macular oedema: real-world results in the UK
    Alfaqawi, Fadi
    Sarmad, Ambreen
    Lip, Peck-Lin
    Elsherbiny, Samer
    Chavan, Randhir
    Mitra, Arijit
    Mushtaq, Bushra
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [47] Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study
    Khoramnia, Ramin
    Peto, Tunde
    Koch, Frank
    Taylor, Simon R.
    Castro de Sousa, Joao Paulo
    Hill, Lauren
    Bailey, Clare
    Chakravarthy, Usha
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (10) : 1502 - 1508
  • [48] Fluocinolone acetonide implant (Iluvien®) for macular edema associated with retinitis pigmentosa: A case report
    Jomaa, Emilie
    Delyfer, Marie-Noelle
    Korobelnik, Jean-Francois
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (06) : NP96 - NP99
  • [49] Treatment of Intractable Posterior Uveitis in Pediatric Patients With the Fluocinolone Acetonide Intravitreal Implant (Retisert)
    Patel, C. C.
    Mandava, N.
    Quiroz-Mercado, H.
    Oliver, S. C.
    Braverman, R.
    Olson, J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [50] Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant
    Ciulla, Thomas A.
    Harris, Alon
    McIntyre, Nathaniel
    Jonescu-Cuypers, Christian
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 953 - 959
12345